Shares of LightPath Technologies surged another 10.3% to $18.70 in pre-market trading on May 26, extending a staggering 50% climb over five sessions as investors continue to price in the company's pivot toward high-value defense contracts enabled by its recent acquisition of Visimid Technologies. LightPath's Defense Bet Has Sent Shares Soaring 50% in a Week — Can a Money-Losing Optics Maker Justify a Billion-Dollar Valuation?
Shares of LightPath Technologies rocketed another 10.3% to $18.70 in pre-market Monday, extending a breathtaking 50% five-day surge as Wall Street continues to reprice the tiny Orlando-based infrared optics maker around Pentagon drone work and a potentially transformative Lockheed Martin missile contract — all stemming from its 2023 Visimid acquisition.
• A Single Missile Contract Could Dwarf the Entire Company's Revenue. The Visimid acquisition has yielded a development contract with Lockheed Martin for a new missile program, with the potential to generate $50–$100 million annually — from just one program. Over the program's life, management has floated $500 million to $1 billion in cumulative revenue. For context, LightPath's trailing twelve-month revenue is just $62.8 million , meaning a Lockheed win could roughly double the top line. The program — a next-generation short-range interceptor to replace the Stinger missile — is LightPath's largest opportunity, though Raytheon is the competing bidder.
• Revenue Is Growing Fast, but Profits Remain Elusive. Q2 fiscal 2026 revenue soared 120% year-over-year to $16.4 million, driven by defense and commercial optics demand. The most recent quarter pushed that higher: on May 7, LPTH reported revenue of $19.15 million, beating estimates by 10%. Yet trailing net income remains negative $14.9 million , and net profit margin sits at -40%. The stock now trades at roughly 13× trailing sales with a market cap approaching $1.06 billion — a valuation that prices in execution that hasn't happened yet.
• China's Germanium Ban Hands LightPath a Geopolitical Advantage. China has tightened germanium exports — a key material for infrared optics — and LightPath's proprietary BlackDiamond glass is stepping in as an alternative.
Management says dependence on China has dropped from 55% of business to under 5%. That supply-chain independence is exactly what the Pentagon wants from its vendors, making LightPath a preferred partner at a time when defense spending is accelerating.
• The Backlog Is Real, but So Is the Execution Risk. Backlog reached $103 million as of late February 2026 , and the company expects to ship 70% of it this calendar year. However, if LightPath fails to meet delivery schedules, it could damage relationships with key defense primes like Lockheed Martin.
Scaling production of its specialty glass for high-volume programs may expose yield and defect challenges not yet fully tested. For a company with just 350 employees , converting a billion-dollar pipeline into shipped hardware is the bet investors are now making at 50% above last week's price.